The initial public offer of Mankind Pharma of Rs 4,326.36 crore subscription will close today. The issue has been subscribed fully with 1.03 times at 11.00 AM. Click here to subscribe the IPO.
Retail investors have bid for 0.32 times of the share set aside for them. 35% of the IPO has been reserved for retail investors.
High net-worth individuals (HNIs) have bought 73,53,021 equity shares against their quota of 60 lakh shares, while qualified institutional buyers (QIBs) have bid for 1,69,30,173 equity shares , so far, against 80.11 lakh shares reserved for them.
The company has fixed the price band of Rs 1026-1080 per share. Investors can bid for 13 shares in a lot and its multiples.
Mankind Pharma IPO important details
| Open date | April 25 |
| Close date | April 27 |
| Lot size | 13 |
| IPO size (Rs crore) | Rs 4,326.36 Cr |
| IPO price range (Rs) | Rs 1026-1080 per share |
| Minimum investment | Rs 14,040 |
| Basis of allotment date | May 3 |
| Refunds date | May 4 |
| Credit to demat account date | May 5 |
| Listing date | May 8 |
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
